Therapy for and prevention of traveler's diarrhea.

  title={Therapy for and prevention of traveler's diarrhea.},
  author={H L DuPont},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  volume={45 Suppl 1},
  • H L DuPont
  • Published in
    Clinical infectious diseases : an official…
Acute diarrhea associated with international travel is commonly caused by enterotoxigenic Escherichia coli, enteroaggregative E. coli, or noroviruses. Early studies to define these enteropathogens took place at the University of Maryland during the Theodore E. Woodward years. Although a reduction in the rate of diarrhea may be possible through avoidance of foods and beverages likely to be contaminated, a more effective preventive strategy is to administer nonabsorbed (<0.4%) rifaximin each day… CONTINUE READING
Highly Cited
This paper has 23 citations. REVIEW CITATIONS

From This Paper

Figures, tables, and topics from this paper.


Publications referenced by this paper.
Showing 1-10 of 50 references

Prevention of travelers’ diarrhea with rifaximin: a phase 3, randomized, double-blind, placebocontrolled trial in US students in Mexico [abstract 516

  • HL DuPont, CD Ericsson, Z-D Jiang
  • Abstracts of the American College of…
  • 2006